A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera (Dimethyl Fumarate) Delayed-release Capsules
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms MANAGE
- Sponsors Biogen Idec
- 21 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2013 Planned end date changed from 1 Sep 2014 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 26 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.